Research Triangle Park, NC, United States of America

Kelly H Donaldson

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kelly H Donaldson. Retrieved from https://idiyas.com/inventor/kelly-h-donaldson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kelly H. Donaldson: Innovator in Pharmaceutical Compounds

Introduction

Kelly H. Donaldson is a notable inventor based in Research Triangle Park, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. Her work has led to the filing of a patent that showcases her innovative approach to drug formulation.

Latest Patents

Kelly H. Donaldson holds a patent for a compound of formula I, which includes a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof. This invention represents a step forward in the pharmaceutical industry, providing new avenues for therapeutic applications.

Career Highlights

Donaldson is currently employed at SmithKline Beecham Corporation, where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking projects.

Collaborations

One of her notable collaborators is Jerzy Ryszard Szewczyk, with whom she has worked closely on various projects. Their partnership exemplifies the importance of teamwork in driving innovation within the pharmaceutical sector.

Conclusion

Kelly H. Donaldson's contributions to the field of pharmaceuticals through her innovative patent and collaborative efforts highlight her role as a key inventor in the industry. Her work continues to pave the way for advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…